Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BOPH
Bohai Pharmaceuticals Group
$0.00
$0.00
$0.00
▼
$0.00
$20K1.7830,425 shs50,000 shs
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
$0.00
$0.00
▼
$0.04
$32K-0.7762,884 shsN/A
SUWN
Sunwin Stevia International
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
$0.00
-50.0%		$0.01
$0.00
▼
$0.20
$30K-74.5312,589 shs576 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BOPH
Bohai Pharmaceuticals Group
0.00%0.00%0.00%0.00%0.00%
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
0.00%0.00%0.00%0.00%0.00%
SUWN
Sunwin Stevia International
0.00%0.00%0.00%0.00%0.00%
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
+100.00%+100.00%+100.00%+100.00%-99.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BOPH
Bohai Pharmaceuticals Group
$0.00
$0.00
$0.00
▼
$0.00
$20K1.7830,425 shs50,000 shs
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
$0.00
$0.00
▼
$0.04
$32K-0.7762,884 shsN/A
SUWN
Sunwin Stevia International
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
$0.00
-50.0%		$0.01
$0.00
▼
$0.20
$30K-74.5312,589 shs576 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BOPH
Bohai Pharmaceuticals Group
0.00%0.00%0.00%0.00%0.00%
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
0.00%0.00%0.00%0.00%0.00%
SUWN
Sunwin Stevia International
0.00%0.00%0.00%0.00%0.00%
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
+100.00%+100.00%+100.00%+100.00%-99.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BOPH
Bohai Pharmaceuticals Group
0.00
N/AN/AN/A
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
0.00
N/AN/AN/A
SUWN
Sunwin Stevia International
0.00
N/AN/AN/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BOPH
Bohai Pharmaceuticals Group
N/AN/AN/AN/AN/AN/A
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
N/AN/AN/AN/AN/AN/A
SUWN
Sunwin Stevia International
N/AN/AN/AN/AN/AN/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BOPH
Bohai Pharmaceuticals Group
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
N/AN/AN/AN/AN/AN/AN/AN/AN/A
SUWN
Sunwin Stevia International
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
-$56.93M-$0.30N/AN/AN/AN/AN/AN/A11/11/2026 (Estimated)
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BOPH
Bohai Pharmaceuticals Group
N/AN/AN/AN/AN/A
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
N/AN/AN/AN/AN/A
SUWN
Sunwin Stevia International
N/AN/AN/AN/AN/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BOPH
Bohai Pharmaceuticals Group
N/A
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
N/A
SUWN
Sunwin Stevia International
N/A
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
82.95%

Insider Ownership

CompanyInsider Ownership
BOPH
Bohai Pharmaceuticals Group
N/A
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
N/A
SUWN
Sunwin Stevia International
0.90%
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
64.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
BOPH
Bohai Pharmaceuticals Group
N/A19.52 millionN/ANot Optionable
Predictive Technology Group, Inc. stock logo
PRED
Predictive Technology Group
62316.67 millionN/ANot Optionable
SUWN
Sunwin Stevia International
240N/AN/ANot Optionable
Vaxxinity, Inc. stock logo
VAXX
Vaxxinity
90126.75 million45.55 millionNot Optionable

Recent News About These Companies

Vaxxinity Inc.
May 25, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/vaxx/financials
Brain health
October 24, 2024  |  newsweek.comN
Treatment Trials in Alzheimer's Disease
September 30, 2024  |  msn.comhttps://www.msn.com/en-au/health/other/treatment-trials-in-alzheimer-s-disease/ar-BB1mwHGY
Is Vaxxinity Inc (VAXX) Stock a Good Investment?
September 19, 2024  |  aaii.comA
Congress makes $4.5 trading stocks in a day; Here's the biggest winners
July 4, 2024  |  finbold.comF
Vaxxinity UB-312 Parkinson's Trial Results Published in Nature Medicine
June 20, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/06/20/2901487/0/en/vaxxinity-ub-312-parkinson-s-trial-results-published-in-nature-medicine.html
Why Is Vaxxinity (VAXX) Stock Up 39% Today?
May 3, 2024  |  investorplace.comhttps://investorplace.com/2024/05/why-is-vaxxinity-vaxx-stock-up-39-today/
Why Is Vaxxinity (VAXX) Stock Down 58% Today?
April 22, 2024  |  investorplace.comhttps://investorplace.com/2024/04/why-is-vaxxinity-vaxx-stock-down-58-today/
Vaxxinity Plans to Delist Shares From Nasdaq
April 19, 2024  |  marketwatch.comhttps://www.marketwatch.com/story/vaxxinity-plans-to-delist-shares-from-nasdaq-0b4e6e00
Vaxxinity Issues Shareholder Letter
April 19, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/04/19/2866409/0/en/vaxxinity-issues-shareholder-letter.html
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
April 19, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/04/19/2866373/0/en/vaxxinity-announces-intention-to-voluntarily-delist-and-deregister-its-class-a-common-stock.html
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
March 28, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/03/28/2854092/0/en/vaxxinity-to-present-clinical-data-at-the-annual-academy-of-neurology-2024-annual-meeting.html
VAXX Stock Earnings: Vaxxinity Beats EPS for Q4 2023
March 27, 2024  |  investorplace.comhttps://investorplace.com/earning-results/2024/03/vaxx-stock-earnings-vaxxinity-for-q4-of-2023/?cc=marketbeat&cp=pdtk
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
March 27, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/03/27/2853637/0/en/vaxxinity-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-corporate-updates.html
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD™ 2024
March 7, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/03/07/2842413/0/en/vaxxinity-announces-positive-target-engagement-data-from-phase-1-clinical-trial-for-parkinson-s-disease-at-ad-pd-2024.html
Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels
February 15, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/vaxxinity-heart-health-innovation-reduces-162929693.html?.tsrc=rss
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
February 15, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/vaxxinity-cholesterol-vaccine-candidate-successfully-130000609.html?.tsrc=rss
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
February 13, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/vaxxinity-present-clinical-preclinical-pipeline-130000495.html?.tsrc=rss
Vaxxinity, UF Join Forces Against Neurodegenerative Diseases
January 30, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/vaxxinity-uf-join-forces-against-172744138.html?.tsrc=rss
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
January 30, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/vaxxinity-announces-research-collaboration-active-130000259.html?.tsrc=rss

New MarketBeat Followers Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Smartphone displaying the DraftKings logo beside a football, basketball, cash, and a neon Bet Live Now sign.
DraftKings’ Predictions Push Could Be the Bet That Matters Most
By Chris Markoch | August 12, 2026

Bohai Pharmaceuticals Group OTCMKTS:BOPH

$0.0010 0.00 (0.00%)
As of 03/11/2019

Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.

Predictive Technology Group stock logo

Predictive Technology Group OTCMKTS:PRED

Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications. It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah. On November 9, 2023, Predictive Technology Group, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Utah. On January 12, 2024, the voluntary petition of Predictive Technology Group, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on November 9, 2023.

Sunwin Stevia International OTCMKTS:SUWN

Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.

Vaxxinity stock logo

Vaxxinity OTCMKTS:VAXX

$0.0001 0.00 (-50.00%)
As of 01:59 PM Eastern

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas